Yazar "Kıvrak, Tarık" için TR-Dizin İndeksli Yayınlar Koleksiyonu listeleme
-
Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: the ATA study
Kocabaş, Umut; Kıvrak, Tarık; Öztekin, Gülsüm Meral Öztekin; Tanık, Veysel Ozan; Özdemir, İbrahim; Tanık, Veysel Ozan; Kaya, Ersin; Yüce, Elif İlkay; Demir, Fulya Avcı; Doğduş, Mustafa; Altınsoy, Meltem; Üstündağ, Songül; Özyurtlu, Ferhat; Karagöz, Uğur; Karakuş, Alper; Urgun, Örsan Deniz; Sinan, Ümit Yaşar; Mutlu, İnan; Şen, Taner; Astarcıoğlu, Mehmet Ali; Kınık, Mustafa; Tok, Özge Özden; Uygur, Begüm; Yeni, Mehtap; Alan, Bahadır; Dalgıç, Onur; Sarıtürk, Çağla; Altay, Hakan; Pehlivanoğlu, Seçkin (2020)Objective: Despite recommendations from heart failure guidelines on the use of pharmacologic and device therapy in patients with heart failure with reduced ejection fraction (HFrEF), important inconsistencies in guideline ... -
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
Ekici, Berkay; Yaman, Mehmet; Küçük, Murathan; Dereli, Seçkin; Yenerçağ, Mustafa; Yiğit, Zerrin; Baş, Mehmet Memduh; Karavelioğlu, Yusuf; Çakmak, Hüseyin Altuğ; Kıvrak, Tarık; Özkan, Hakan; Altın, Cihan; Şabanoğlu, Cengiz; Demirkan, Burcu; Ataş, Ali Ekber; Kılıçaslan, Fethi; Altay, Hakan; Tengiz, İstemihan; Erkan, Aycan Fahri; Kılıçaslan, Barış; Olgun, Fatih Erkam; Durakoğlugil, Murtaza Emre; Alhan, Aslıhan; Zoghi, Mehdi (AVES, 2021)Objective: Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection ...